Fort Baker Capital Management LP lessened its stake in Liberty Broadband Co. (NASDAQ:LBRDK – Free Report) by 86.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 43,572 shares of the company’s stock after selling 289,143 shares during the quarter. Fort Baker […]
Invenomic Capital Management LP increased its stake in 3M (NYSE:MMM – Free Report) by 25.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 154,996 shares of the conglomerate’s stock after buying an additional 31,017 shares during the quarter. Invenomic […]
Invenomic Capital Management LP lowered its holdings in shares of CVS Health Co. (NYSE:CVS – Free Report) by 42.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 154,047 shares of the pharmacy operator’s stock after selling 111,529 shares during the period. […]
Invenomic Capital Management LP lowered its stake in Comcast Co. (NASDAQ:CMCSA – Free Report) by 23.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 842,194 shares of the cable giant’s stock after selling 251,471 shares during the period. Comcast accounts […]
Shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) have earned a consensus rating of “Buy” from the ten brokerages that are covering the company, MarketBeat Ratings reports. Ten investment analysts have rated the stock with a buy recommendation. The average 12 month price target among brokers that have updated their coverage on the […]